(Q34605987)

English

A promoter haplotype of the inositol monophosphatase 2 gene (IMPA2) at 18p11.2 confers a possible risk for bipolar disorder by enhancing transcription

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

A promoter haplotype of the inositol monophosphatase 2 gene (IMPA2) at 18p11.2 confers a possible risk for bipolar disorder by enhancing transcription (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

bipolar disorder

1 reference

based on heuristic

inferred from title

Kenji J. Tsuchiya

object named as

Kenji J Tsuchiya

15

0 references

object named as

Hiroshi Kunugi

8

0 references

object named as

Tadafumi Kato

20

0 references

object named as

Norio Ozaki

10

0 references

5

object named as

Tomoko Toyota

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Yoshimi Iwayama

4

object named as

Yoshimi Iwayama

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

2

object named as

Kazuo Yamada

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

6

object named as

Eiji Hattori

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

11

object named as

Nakao Iwata

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Masahiko Tatsumi

9

object named as

Masahiko Tatsumi

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

13

object named as

Yoshimi Iijima

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Shinichiro Nanko

17

object named as

Shinichiro Nanko

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

1

object named as

Tetsuo Ohnishi

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

14

object named as

Yasuhide Iwata

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Genichi Sugihara

16

object named as

Genichi Sugihara

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

3

object named as

Hisako Ohba

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Sevilla D Detera-Wadleigh

19

object named as

Sevilla D Detera-Wadleigh

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

author name string

Toshiya Inada

7

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Kaoru Sakamoto

12

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Noriko Osumi

18

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Takeo Yoshikawa

21

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

language of work or name

0 references

publication date

24 January 2007

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Neuropsychopharmacology

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

32

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

1727-1737

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

https://scigraph.springernature.com/pub.10.1038/sj.npp.1301307

0 references

A haplotype map of the human genome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301307

21 January 2018

A family-based association study and gene expression analyses of netrin-G1 and -G2 genes in schizophrenia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301307

21 January 2018

Haploview: analysis and visualization of LD and haplotype maps

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301307

21 January 2018

Reduced inositol content in lymphocyte-derived cell lines from bipolar patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301307

21 January 2018

Chromosome 18 DNA markers and manic-depressive illness: evidence for a susceptibility gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301307

21 January 2018

Neural and developmental actions of lithium: a unifying hypothesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301307

21 January 2018

Allele-specific gene expression differences in humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301307

21 January 2018

Alternative transcripts and evidence of imprinting of GNAL on 18p11.2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301307

21 January 2018

Epigenetic regulation of mammalian genomic imprinting

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301307

21 January 2018

A high-density genome scan detects evidence for a bipolar-disorder susceptibility locus on 13q32 and other potential loci on 1q32 and 18p11.2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301307

21 January 2018

Advances in myeloma genetics and prospects for pharmacogenomic testing in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301307

21 January 2018

Lithium in bipolar mood disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301307

21 January 2018

Pedigree disequilibrium tests for multilocus haplotypes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301307

21 January 2018

Mood disorders in the medically ill: scientific review and recommendations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301307

21 January 2018

The structure of haplotype blocks in the human genome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301307

21 January 2018

Emerging experimental therapeutics for bipolar disorder: insights from the molecular and cellular actions of current mood stabilizers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301307

21 January 2018

Lithium and valproic acid: parallels and contrasts in diverse signaling contexts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301307

21 January 2018

Lithium and bipolar mood disorder: the inositol-depletion hypothesis revisited

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301307

21 January 2018

Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301307

21 January 2018

No association between the Val66Met polymorphism of the brain-derived neurotrophic factor gene and bipolar disorder in a Japanese population: a multicenter study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301307

21 January 2018

Assessment of the effect of age at onset on linkage to bipolar disorder: evidence on chromosomes 18p and 21q

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301307

21 January 2018

Mitochondrial DNA 3644T-->C mutation associated with bipolar disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301307

21 January 2018

Linkage and association of febrile seizures to the IMPA2 gene on human chromosome 18.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301307

21 January 2018

Effect of bipolar disorder on lymphocyte inositol monophosphatase mRNA levels

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301307

21 January 2018

Spatial expression patterns and biochemical properties distinguish a second myo-inositol monophosphatase IMPA2 from IMPA1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301307

21 January 2018

Lithium modulation of the human inositol monophosphatase 2 (IMPA2) promoter

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301307

21 January 2018

Genome scan meta-analysis of schizophrenia and bipolar disorder, part III: Bipolar disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301307

21 January 2018

Inositol monophosphatase activity in brain and lymphocyte-derived cell lines of bipolar patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301307

21 January 2018

Inositol monophosphatase in immortalized lymphoblastoid cell lines indicates susceptibility to bipolar disorder and response to lithium therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301307

21 January 2018

Examination of IMPA1 and IMPA2 genes in manic-depressive patients: association between IMPA2 promoter polymorphisms and bipolar disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301307

21 January 2018

A human myo-inositol monophosphatase gene (IMPA2) localized in a putative susceptibility region for bipolar disorder on chromosome 18p11.2: genomic structure and polymorphism screening in manic-depressive patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301307

21 January 2018

Transcriptional down-regulation of MARCKS gene expression in immortalized hippocampal cells by lithium

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301307

21 January 2018

A common mechanism of action for three mood-stabilizing drugs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301307

21 January 2018

Identification of multiple serine racemase (SRR) mRNA isoforms and genetic analyses of SRR and DAO in schizophrenia and D-serine levels

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301307

21 January 2018

Altered IMPA2 gene expression and calcium homeostasis in bipolar disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301307

21 January 2018

Evidence for association of the myo-inositol monophosphatase 2 (IMPA2) gene with schizophrenia in Japanese samples.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301307

21 January 2018

Genomic structure and novel variants of myo-inositol monophosphatase 2 (IMPA2).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301307

21 January 2018

A novel human myo-inositol monophosphatase gene, IMP.18p, maps to a susceptibility region for bipolar disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301307

21 January 2018

The stanley foundation brain collection and neuropathology consortium

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1301307

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.NPP.1301307

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34605987&oldid=1971831700"